Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?

Stoicescu A, Andrei M, Becheanu G, Stoicescu M, Nicolaie T, Diculescu M.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):766-72.

PMID:
23272525
2.

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A.

World J Gastroenterol. 2009 Jun 7;15(21):2628-31.

3.

A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.

Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.

Neurogastroenterol Motil. 2014 Jun;26(6):794-802. doi: 10.1111/nmo.12331. Epub 2014 Mar 18.

4.

Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.

Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.

Rom J Intern Med. 2014;52(3):143-50.

PMID:
25509557
5.

Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.

Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitraşcu DL.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):143-7.

PMID:
24620626
6.

Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.

Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20.

7.

Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.

Petrone P, Sarkisyan G, Fernández M, Coloma E, Akopian G, Ortega A, Kaufman HS.

Arch Surg. 2011 Apr;146(4):444-7. doi: 10.1001/archsurg.2011.55.

PMID:
21502453
8.

[Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].

Łokieć K, Klupińska G, Walecka-Kapica E, Błońska A.

Pol Merkur Lekarski. 2014 May;36(215):307-10. Polish.

PMID:
24964506
9.

Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.

Weinstock LB, Geng B, Brandes SB.

Can J Urol. 2011 Aug;18(4):5826-30.

PMID:
21854715
10.

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M.

Gut. 2007 Jun;56(6):802-8. Epub 2006 Dec 5.

11.

Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Reddymasu SC, Sostarich S, McCallum RW.

BMC Gastroenterol. 2010 Feb 22;10:23. doi: 10.1186/1471-230X-10-23.

12.

Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy.

Weinstock LB, Fern SE, Duntley SP.

Dig Dis Sci. 2008 May;53(5):1252-6. Epub 2007 Oct 13.

PMID:
17934858
13.

Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Esposito I, de Leone A, Di Gregorio G, Giaquinto S, de Magistris L, Ferrieri A, Riegler G.

World J Gastroenterol. 2007 Dec 7;13(45):6016-21.

14.

Symptomatic overlap in patients with diarrhea predominant irritable bowel syndrome and microscopic colitis in a sub group of Bangladeshi population.

Rahman MA, Raihan AS, Ahamed DS, Masud H, Safiullah AB, Khair KB, Salimullah AS, Islam MM.

Bangladesh Med Res Counc Bull. 2012 Apr;38(1):33-8.

PMID:
22545349
15.

Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Rana SV, Sharma S, Kaur J, Sinha SK, Singh K.

Digestion. 2012;85(3):243-7. doi: 10.1159/000336174. Epub 2012 Mar 30.

PMID:
22472730
16.

Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.

Cuoco L, Salvagnini M.

Minerva Gastroenterol Dietol. 2006 Mar;52(1):89-95.

PMID:
16554709
17.

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.

Boltin D, Perets TT, Shporn E, Aizic S, Levy S, Niv Y, Dickman R.

Ann Clin Microbiol Antimicrob. 2014 Oct 17;13:49. doi: 10.1186/s12941-014-0049-x.

18.

Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.

Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):371-5. doi: 10.4103/1319-3767.87176.

19.

Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.

Parodi A, Dulbecco P, Savarino E, Giannini EG, Bodini G, Corbo M, Isola L, De Conca S, Marabotto E, Savarino V.

J Clin Gastroenterol. 2009 Nov-Dec;43(10):962-6. doi: 10.1097/MCG.0b013e3181a099a5.

PMID:
19525858
Items per page

Supplemental Content

Write to the Help Desk